Dialysis and Transplantation News
The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry
F Locatelli, F Conte, and D Marcelli
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
This article has been cited by other articles:
![]() |
U. P. Udayaraj, Y. Ben-Shlomo, P. Roderick, R. Steenkamp, D. Ansell, C. R.V. Tomson, and F. J. Caskey Ethnicity, Socioeconomic Status, and Attainment of Clinical Practice Guideline Standards in Dialysis Patients in the United Kingdom Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 979 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. von Drygalski and J. Biller Anemia in Cystic Fibrosis: Incidence, Mechanisms, and Association With Pulmonary Function and Vitamin Deficiency Nutr Clin Pract, October 1, 2008; 23(5): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kilpatrick, C. W. Critchlow, S. Fishbane, A. Besarab, C. Stehman-Breen, M. Krishnan, and B. D. Bradbury Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tomasello Anemia of Chronic Kidney Disease Journal of Pharmacy Practice, June 1, 2008; 21(3): 181 - 195. [Abstract] [PDF] |
||||
![]() |
J. Portoles, J. M. Lopez-Gomez, P. Aljama, and on behalf of the MAR Study Group A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study Nephrol. Dial. Transplant., February 1, 2007; 22(2): 500 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Locatelli, L. Del Vecchio, and P. Pozzoni Anemia and Cardiovascular Risk: The Lesson of the CREATE Trial J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S262 - S266. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Roberts, R. N. Foley, E. D. Weinhandl, D. T. Gilbertson, and A. J. Collins Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1652 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Regidor, J. D. Kopple, C. P. Kovesdy, R. D. Kilpatrick, C. J. McAllister, J. Aronovitz, S. Greenland, and K. Kalantar-Zadeh Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1181 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Port, R. L. Pisoni, J. Bommer, F. Locatelli, M. Jadoul, G. Eknoyan, K. Kurokawa, B. J. Canaud, M. P. Finley, and E. W. Young Improving Outcomes for Dialysis Patients in the International Dialysis Outcomes and Practice Patterns Study Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 246 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chesterton, S. H. Lambie, L. J. Hulme, M. Taal, R. J. Fluck, and C. W. McIntyre Online measurement of haemoglobin concentration Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1951 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Feldman, M. Joffe, B. Robinson, J. Knauss, B. Cizman, W. Guo, E. Franklin-Becker, and G. Faich Administration of Parenteral Iron and Mortality among Hemodialysis Patients J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1623 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Locatelli, R. L. Pisoni, C. Combe, J. Bommer, V. E. Andreucci, L. Piera, R. Greenwood, H. I. Feldman, F. K. Port, and P. J. Held Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Nephrol. Dial. Transplant., January 1, 2004; 19(1): 121 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Snyder, R. N. Foley, D. T. Gilbertson, E. F. Vonesh, and A. J. Collins Hemoglobin Levels and Erythropoietin Doses in Hemodialysis and Peritoneal Dialysis Patients in the United States J. Am. Soc. Nephrol., January 1, 2004; 15(1): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Toprak, M. Koc, H. Tezcan, I. C. Ozener, E. Akoglu, and A. Oktay Inferior vena cava diameter determines left ventricular geometry in continuous ambulatory peritoneal dialysis patients: an echocardiographic study Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2128 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Macdougall CREATE: new strategies for early anaemia management in renal insufficiency Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii13 - ii16. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Jungers, C. Robino, G. Choukroun, T. Nguyen-Khoa, Z. A. Massy, and P. Jungers Incidence of anaemia, and use of epoetin therapy in pre-dialysis patients: a prospective study in 403 patients Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1621 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E Marsh and P. A Andrews Management of the diabetic patient approaching end-stage renal failure The British Journal of Diabetes & Vascular Disease, March 1, 2002; 2(2): 121 - 126. [PDF] |
||||
![]() |
F. Locatelli, L. D. Vecchio, and S. Andrulli The modality of dialysis treatment: does it influence the response to erythropoietin treatment? Nephrol. Dial. Transplant., October 1, 2001; 16(10): 1971 - 1974. [Full Text] [PDF] |
||||
![]() |
D. S. Silverberg, D. Wexler, D. Sheps, M. Blum, G. Keren, R. Baruch, D. Schwartz, T. Yachnin, S. Steinbruch, I. Shapira, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1775 - 1780. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. MIDDLETON, P. S. PARFREY, and R. N. FOLEY Left Ventricular Hypertrophy in the Renal Patient J. Am. Soc. Nephrol., May 1, 2001; 12(5): 1079 - 1084. [Full Text] |
||||
![]() |
F. Locatelli, S. Andrulli, F. Pecchini, L. Pedrini, S. Agliata, L. Lucchi, M. Farina, V. La Milia, C. Grassi, M. Borghi, et al. Effect of high-flux dialysis on the anaemia of haemodialysis patients Nephrol. Dial. Transplant., September 1, 2000; 15(9): 1399 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Silverberg, D. Wexler, M. Blum, G. Keren, D. Sheps, E. Leibovitch, D. Brosh, S. Laniado, D. Schwartz, T. Yachnin, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1737 - 1744. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Will and J. S. Cameron European guidelines for renal anaemia--predicting 85% compliance Nephrol. Dial. Transplant., March 1, 2000; 15(3): 439 - 440. [Full Text] [PDF] |
||||
![]() |
F. MORENO, D. SANZ-GUAJARDO, J. M. LOPEZ-GOMEZ, R. JOFRE, and F. VALDERRABANO Increasing the Hematocrit Has a Beneficial Effect on Quality of Life and Is Safe in Selected Hemodialysis Patients J. Am. Soc. Nephrol., February 1, 2000; 11(2): 335 - 342. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






